Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Akk Biotek Holding ApS
APS
Active
CVR 39641747
Søndervigvej 50
Activities of holding companies · NACE 6421
Est. 2018
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 9K
EBITDA margin
100.0%
Equity ratio
93.7%
Financial strength
Net profit 2024
DKK 9K
+539% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 9K
—
EBITDA
DKK 9K
—
Net profit
DKK 9K
+539%
Total assets
DKK 208K
-3%
Equity
DKK 195K
+5%
Employees
—
—
Company information
Legal name
Akk Biotek Holding ApS
CVR number
39641747
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
13. juni 2018
Share capital
DKK 115.325
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen
Company purpose
1.2 Selskabets formål er udelukkende at eje drift selskabet VulCur Medtech ApS.
Contact
Address
Søndervigvej 50
Phone
+4542652294
Email
janus.larsen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of holding companies
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-4
-8
-5
—
9
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-4
-8
-5
0
9
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-4
-8
-5
0
9
Net financials
-3
-1
-1
-2
-1
Profit before tax
-7
-9
-6
-2
9
Tax
-0
-4
-0
-0
-0
Net profit
-7
-5
-6
-2
9
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
629
221
216
214
208
Equity
199
193
188
186
195
Long-term debt
0
0
0
0
0
Short-term debt
430
27
27
27
13
Total debt
430
27
27
27
13
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2020
2024
Equity ratio
93.7%
This company
38.2%
Market median
+145% vs market
2020
2024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
2020
2024
Net profit margin
91.9%
This company
8.1%
Market median
+1035% vs market
2020
2024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Janus Beierholm
Individual
100%
100%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Akk Biotek Holding ApS
(this company)
Inwound ApS
Board network connections
Board members of Akk Biotek Holding ApS also hold positions in
0
other companies.
Person
Role here
Other companies